X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4781) 4781
Newsletter (106) 106
Book Chapter (10) 10
Magazine Article (10) 10
Book Review (2) 2
Conference Proceeding (2) 2
Newspaper Article (2) 2
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
itraconazole (3408) 3408
humans (2692) 2692
pharmacology & pharmacy (2394) 2394
antifungal agents - pharmacology (1994) 1994
microbiology (1359) 1359
itraconazole - pharmacology (1324) 1324
male (1188) 1188
microbial sensitivity tests (1165) 1165
fluconazole (1005) 1005
voriconazole (986) 986
female (952) 952
animals (865) 865
antifungal agents - therapeutic use (859) 859
adult (790) 790
amphotericin-b (671) 671
infectious diseases (661) 661
antifungal agents (653) 653
fluconazole - pharmacology (642) 642
triazoles - pharmacology (604) 604
pharmacokinetics (577) 577
amphotericin b - pharmacology (575) 575
mycology (572) 572
drug interactions (561) 561
middle aged (559) 559
susceptibility (478) 478
itraconazole - therapeutic use (476) 476
antifungal agents - administration & dosage (472) 472
in-vitro (435) 435
drug resistance, fungal (419) 419
candida - drug effects (402) 402
itraconazole - administration & dosage (397) 397
solubility (383) 383
ketoconazole (380) 380
posaconazole (376) 376
antifungal agents - pharmacokinetics (368) 368
terbinafine (346) 346
amphotericin b (340) 340
ketoconazole - pharmacology (340) 340
drugs (339) 339
administration, oral (328) 328
pyrimidines - pharmacology (326) 326
aged (312) 312
analysis (306) 306
resistance (305) 305
aspergillus fumigatus - drug effects (304) 304
itraconazole - pharmacokinetics (296) 296
mice (293) 293
microbial sensitivity tests - methods (286) 286
mycoses (280) 280
infections (279) 279
itraconazole - chemistry (274) 274
therapy (267) 267
pharmacology (258) 258
candida albicans - drug effects (254) 254
aspergillosis - drug therapy (253) 253
fungi (246) 246
adolescent (237) 237
bioavailability (237) 237
epidemiology (235) 235
antifungal agents - adverse effects (233) 233
treatment outcome (233) 233
dermatology (231) 231
area under curve (228) 228
antifungal (227) 227
aspergillosis - microbiology (225) 225
triazoles - therapeutic use (224) 224
research (222) 222
azoles - pharmacology (221) 221
mycoses - drug therapy (220) 220
aspergillosis (219) 219
metabolism (219) 219
dissolution (218) 218
dose-response relationship, drug (217) 217
candida-albicans (216) 216
chemistry, medicinal (213) 213
invasive aspergillosis (212) 212
infection (211) 211
aspergillus - drug effects (210) 210
caspofungin (207) 207
antifungal susceptibility (205) 205
rats (204) 204
azoles (203) 203
pharmacology/toxicology (203) 203
antifungal agents - chemistry (196) 196
aspergillus (195) 195
fluconazole - therapeutic use (192) 192
amphotericin b - therapeutic use (191) 191
veterinary sciences (190) 190
health aspects (187) 187
candida - isolation & purification (186) 186
cross-over studies (186) 186
candidiasis - microbiology (184) 184
agents (181) 181
candidiasis - drug therapy (180) 180
fungal-infections (179) 179
research article (177) 177
naphthalenes - pharmacology (172) 172
biological availability (165) 165
young adult (165) 165
ketoconazole - analogs & derivatives (164) 164
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4780) 4780
Japanese (88) 88
German (65) 65
Spanish (59) 59
Portuguese (40) 40
French (37) 37
Turkish (11) 11
Chinese (9) 9
Polish (9) 9
Dutch (3) 3
Italian (3) 3
Russian (3) 3
Bulgarian (1) 1
Lithuanian (1) 1
Persian (1) 1
Serbian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Antimicrobial agents and chemotherapy, ISSN 1098-6596, 2012, Volume 56, Issue 11, pp. 5898 - 5906
Epidemiological cutoff values (ECVs) for the species complex versus fluconazole, itraconazole, posaconazole, and voriconazole are not available. We established... 
Cryptococcus gattii/drug effects | India/epidemiology | Cryptococcosis/drug therapy | South America/epidemiology | Humans | Australia/epidemiology | Itraconazole/pharmacology | Microbial Sensitivity Tests | Pyrimidines/pharmacology | Triazoles/pharmacology | Fluconazole/pharmacology | Antifungal Agents/pharmacology | Europe/epidemiology | South Africa/epidemiology | Voriconazole | Drug Resistance, Fungal/drug effects | North America/epidemiology | MIC DISTRIBUTIONS | METHOD M38-A2 DOCUMENT | MOLECULAR TYPE | CROSS-RESISTANCE | CLSI BROTH MICRODILUTION | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | IN-VITRO SUSCEPTIBILITY | AMPHOTERICIN-B | ASPERGILLUS SPP | ANTIFUNGAL DRUG SUSCEPTIBILITY | LANOSTEROL 14-ALPHA-DEMETHYLASE | Fluconazole - pharmacology | Cryptococcosis - microbiology | Cryptococcosis - drug therapy | Fluconazole - therapeutic use | Itraconazole - pharmacology | Antifungal Agents - therapeutic use | Cryptococcus gattii - drug effects | South America - epidemiology | Triazoles - therapeutic use | Antifungal Agents - pharmacology | Cryptococcus gattii - growth & development | Drug Resistance, Fungal - drug effects | South Africa - epidemiology | Europe - epidemiology | India - epidemiology | Pyrimidines - pharmacology | Australia - epidemiology | Itraconazole - therapeutic use | Triazoles - pharmacology | Cryptococcus gattii - isolation & purification | Pyrimidines - therapeutic use | Cryptococcosis - epidemiology | North America - epidemiology | Susceptibility
Journal Article
Antimicrobial agents and chemotherapy, ISSN 1098-6596, 2011, Volume 55, Issue 10, pp. 4652 - 4658
Journal Article
Journal Article
Journal Article